Fluorouracil: Active in ZD1694 (Tomudex)-Resistant Cell Lines With Markedly Elevated Thymidylate Synthase Levels

A letter to the editor discusses ZD1694, which is a quinazoline folate that inhibits the catalytic activity of thymidylate synthase. ZD1694 has been safely administered to patients in trials.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JNCI : Journal of the National Cancer Institute 1995-10, Vol.87 (20), p.1558-1559
Hauptverfasser: JOHNSTON, PATRICK G., BEHAN, KATHERINE A., ALLEGRA, CARMEN J., DRAKE, JAMES C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1559
container_issue 20
container_start_page 1558
container_title JNCI : Journal of the National Cancer Institute
container_volume 87
creator JOHNSTON, PATRICK G.
BEHAN, KATHERINE A.
ALLEGRA, CARMEN J.
DRAKE, JAMES C.
description A letter to the editor discusses ZD1694, which is a quinazoline folate that inhibits the catalytic activity of thymidylate synthase. ZD1694 has been safely administered to patients in trials.
doi_str_mv 10.1093/jnci/87.20.1558-a
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77525403</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>6981875</sourcerecordid><originalsourceid>FETCH-LOGICAL-c361t-61268acfa5a7b2199282a783eef0dc268b2051d99155e0a51ea44c5cf0c625503</originalsourceid><addsrcrecordid>eNpdUU1P20AQXVVFNND-AA5Iqx4QHAz74f0wN5RCQEpbqU0F4rLarMfKpms79doR_vcsSsShcxk9vTejmfcQOqHkkpKCX60b56-0umQJC6Ez-wFNaC5JxigRH9GEEKYyrVX-CR3FuCapCpYfokMlJKcFn6DNXRjarh0663y4xjeu91vAvsHP36gscny-aOuhhJeL7BdEH3vb9HgKIeC5byDiR9-v8Hfb_YUyjPg2wNb2UOLFaqx9OYYE8O-x6Vc2Ap7DFkL8jA4qGyJ82fdj9OfudjG9z-Y_Zw_Tm3nmuKR9JimT2rrKCquWjBYF08wqzQEqUrrELRkRtCyK9DcQKyjYPHfCVcRJJgThx-hst3fTtf8GiL2pfXTpcttAO0SjlGAiJzwJv_4nXCc7mnSbYVxIxpVWSUR3Ite1MXZQmU3na9uNhhLzFoV5i8JoZVjCKQpj08zpfvGwrKF8n9h7n_hsxydb4eWdTmYaqbgS5v7p2ajZj9nj0yI3nL8CfWiTxQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>235623787</pqid></control><display><type>article</type><title>Fluorouracil: Active in ZD1694 (Tomudex)-Resistant Cell Lines With Markedly Elevated Thymidylate Synthase Levels</title><source>MEDLINE</source><source>Oxford University Press Journals Digital Archive Legacy</source><creator>JOHNSTON, PATRICK G. ; BEHAN, KATHERINE A. ; ALLEGRA, CARMEN J. ; DRAKE, JAMES C.</creator><creatorcontrib>JOHNSTON, PATRICK G. ; BEHAN, KATHERINE A. ; ALLEGRA, CARMEN J. ; DRAKE, JAMES C.</creatorcontrib><description>A letter to the editor discusses ZD1694, which is a quinazoline folate that inhibits the catalytic activity of thymidylate synthase. ZD1694 has been safely administered to patients in trials.</description><identifier>ISSN: 0027-8874</identifier><identifier>EISSN: 1460-2105</identifier><identifier>DOI: 10.1093/jnci/87.20.1558-a</identifier><identifier>PMID: 7563193</identifier><identifier>CODEN: JNCIEQ</identifier><language>eng</language><publisher>United States: Oxford University Press</publisher><subject>Cancer ; Cellular biology ; Drug Resistance ; Drug therapy ; Fluorouracil - pharmacology ; Humans ; Letters to the editor ; Neoplasms - drug therapy ; Neoplasms - enzymology ; Neoplasms - physiopathology ; Quinazolines - pharmacology ; Thiophenes - pharmacology ; Thymidylate Synthase - analysis ; Thymidylate Synthase - antagonists &amp; inhibitors ; Tumor Cells, Cultured</subject><ispartof>JNCI : Journal of the National Cancer Institute, 1995-10, Vol.87 (20), p.1558-1559</ispartof><rights>Copyright Oxford University Press(England) Oct 18, 1995</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c361t-61268acfa5a7b2199282a783eef0dc268b2051d99155e0a51ea44c5cf0c625503</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7563193$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>JOHNSTON, PATRICK G.</creatorcontrib><creatorcontrib>BEHAN, KATHERINE A.</creatorcontrib><creatorcontrib>ALLEGRA, CARMEN J.</creatorcontrib><creatorcontrib>DRAKE, JAMES C.</creatorcontrib><title>Fluorouracil: Active in ZD1694 (Tomudex)-Resistant Cell Lines With Markedly Elevated Thymidylate Synthase Levels</title><title>JNCI : Journal of the National Cancer Institute</title><addtitle>J Natl Cancer Inst</addtitle><description>A letter to the editor discusses ZD1694, which is a quinazoline folate that inhibits the catalytic activity of thymidylate synthase. ZD1694 has been safely administered to patients in trials.</description><subject>Cancer</subject><subject>Cellular biology</subject><subject>Drug Resistance</subject><subject>Drug therapy</subject><subject>Fluorouracil - pharmacology</subject><subject>Humans</subject><subject>Letters to the editor</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - enzymology</subject><subject>Neoplasms - physiopathology</subject><subject>Quinazolines - pharmacology</subject><subject>Thiophenes - pharmacology</subject><subject>Thymidylate Synthase - analysis</subject><subject>Thymidylate Synthase - antagonists &amp; inhibitors</subject><subject>Tumor Cells, Cultured</subject><issn>0027-8874</issn><issn>1460-2105</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdUU1P20AQXVVFNND-AA5Iqx4QHAz74f0wN5RCQEpbqU0F4rLarMfKpms79doR_vcsSsShcxk9vTejmfcQOqHkkpKCX60b56-0umQJC6Ez-wFNaC5JxigRH9GEEKYyrVX-CR3FuCapCpYfokMlJKcFn6DNXRjarh0663y4xjeu91vAvsHP36gscny-aOuhhJeL7BdEH3vb9HgKIeC5byDiR9-v8Hfb_YUyjPg2wNb2UOLFaqx9OYYE8O-x6Vc2Ap7DFkL8jA4qGyJ82fdj9OfudjG9z-Y_Zw_Tm3nmuKR9JimT2rrKCquWjBYF08wqzQEqUrrELRkRtCyK9DcQKyjYPHfCVcRJJgThx-hst3fTtf8GiL2pfXTpcttAO0SjlGAiJzwJv_4nXCc7mnSbYVxIxpVWSUR3Ite1MXZQmU3na9uNhhLzFoV5i8JoZVjCKQpj08zpfvGwrKF8n9h7n_hsxydb4eWdTmYaqbgS5v7p2ajZj9nj0yI3nL8CfWiTxQ</recordid><startdate>19951018</startdate><enddate>19951018</enddate><creator>JOHNSTON, PATRICK G.</creator><creator>BEHAN, KATHERINE A.</creator><creator>ALLEGRA, CARMEN J.</creator><creator>DRAKE, JAMES C.</creator><general>Oxford University Press</general><general>Superintendent of Documents</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>19951018</creationdate><title>Fluorouracil: Active in ZD1694 (Tomudex)-Resistant Cell Lines With Markedly Elevated Thymidylate Synthase Levels</title><author>JOHNSTON, PATRICK G. ; BEHAN, KATHERINE A. ; ALLEGRA, CARMEN J. ; DRAKE, JAMES C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c361t-61268acfa5a7b2199282a783eef0dc268b2051d99155e0a51ea44c5cf0c625503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Cancer</topic><topic>Cellular biology</topic><topic>Drug Resistance</topic><topic>Drug therapy</topic><topic>Fluorouracil - pharmacology</topic><topic>Humans</topic><topic>Letters to the editor</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - enzymology</topic><topic>Neoplasms - physiopathology</topic><topic>Quinazolines - pharmacology</topic><topic>Thiophenes - pharmacology</topic><topic>Thymidylate Synthase - analysis</topic><topic>Thymidylate Synthase - antagonists &amp; inhibitors</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>JOHNSTON, PATRICK G.</creatorcontrib><creatorcontrib>BEHAN, KATHERINE A.</creatorcontrib><creatorcontrib>ALLEGRA, CARMEN J.</creatorcontrib><creatorcontrib>DRAKE, JAMES C.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>JNCI : Journal of the National Cancer Institute</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>JOHNSTON, PATRICK G.</au><au>BEHAN, KATHERINE A.</au><au>ALLEGRA, CARMEN J.</au><au>DRAKE, JAMES C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fluorouracil: Active in ZD1694 (Tomudex)-Resistant Cell Lines With Markedly Elevated Thymidylate Synthase Levels</atitle><jtitle>JNCI : Journal of the National Cancer Institute</jtitle><addtitle>J Natl Cancer Inst</addtitle><date>1995-10-18</date><risdate>1995</risdate><volume>87</volume><issue>20</issue><spage>1558</spage><epage>1559</epage><pages>1558-1559</pages><issn>0027-8874</issn><eissn>1460-2105</eissn><coden>JNCIEQ</coden><abstract>A letter to the editor discusses ZD1694, which is a quinazoline folate that inhibits the catalytic activity of thymidylate synthase. ZD1694 has been safely administered to patients in trials.</abstract><cop>United States</cop><pub>Oxford University Press</pub><pmid>7563193</pmid><doi>10.1093/jnci/87.20.1558-a</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0027-8874
ispartof JNCI : Journal of the National Cancer Institute, 1995-10, Vol.87 (20), p.1558-1559
issn 0027-8874
1460-2105
language eng
recordid cdi_proquest_miscellaneous_77525403
source MEDLINE; Oxford University Press Journals Digital Archive Legacy
subjects Cancer
Cellular biology
Drug Resistance
Drug therapy
Fluorouracil - pharmacology
Humans
Letters to the editor
Neoplasms - drug therapy
Neoplasms - enzymology
Neoplasms - physiopathology
Quinazolines - pharmacology
Thiophenes - pharmacology
Thymidylate Synthase - analysis
Thymidylate Synthase - antagonists & inhibitors
Tumor Cells, Cultured
title Fluorouracil: Active in ZD1694 (Tomudex)-Resistant Cell Lines With Markedly Elevated Thymidylate Synthase Levels
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T10%3A42%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fluorouracil:%20Active%20in%20ZD1694%20(Tomudex)-Resistant%20Cell%20Lines%20With%20Markedly%20Elevated%20Thymidylate%20Synthase%20Levels&rft.jtitle=JNCI%20:%20Journal%20of%20the%20National%20Cancer%20Institute&rft.au=JOHNSTON,%20PATRICK%20G.&rft.date=1995-10-18&rft.volume=87&rft.issue=20&rft.spage=1558&rft.epage=1559&rft.pages=1558-1559&rft.issn=0027-8874&rft.eissn=1460-2105&rft.coden=JNCIEQ&rft_id=info:doi/10.1093/jnci/87.20.1558-a&rft_dat=%3Cproquest_cross%3E6981875%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=235623787&rft_id=info:pmid/7563193&rfr_iscdi=true